Skip to Main content Skip to Navigation
Journal articles

Viscous Core Liposomes Increase siRNA Encapsulation and Provides Gene Inhibition When Slightly Positively Charged

Abstract : Since its discovery, evidence that siRNA was able to act as an RNA interference effector, led to its acceptation as a novel medicine. The siRNA approach is very effective, due to its catalytic mechanism, but still the limitations of its cellular delivery should be addressed. One promising form of non-viral gene delivery system is liposomes. The variable and versatile nature of the lipids keeps the possibility to upgrade the liposomal structure, which makes them suitable for encapsulation and delivery of drugs. However, to avoid the limitation of fast release for the hydrophilic drug, we previously designed viscous core liposomes. We aimed in this work to evaluate if these viscous core liposomes (NvcLs) could be of interest for siRNA encapsulation. Then, we sought to add a limited amount of positive charges to provide cell interaction and transfection. Cationic lipid dimyristoylaminopropylaminopropyl or the polymer poly(ethylenimine) were incorporated in NvcL to produce positively charged viscous core liposomes (PvcL) by a customized microfluidic device. We found that NvcLs increased the encapsulation efficiency and loading content with regards to the neutral liposome. Both PvcL(PEI) and PvcL(DMAPAP) exhibited transfection and GFP knock-down (approximate to 40%) in both 2D and 3D cell cultures. Finally, the addition of slight positive charges did not induce cell toxicity.
Complete list of metadata

https://hal-cnrs.archives-ouvertes.fr/hal-03290555
Contributor : Colette Orange <>
Submitted on : Monday, July 19, 2021 - 1:40:54 PM
Last modification on : Friday, July 23, 2021 - 3:53:02 AM

Links full text

Identifiers

Collections

Citation

Shayan Ahmed, Hugo Salmon, Nicholas Distasio, Hai Doan Do, Daniel Scherman, et al.. Viscous Core Liposomes Increase siRNA Encapsulation and Provides Gene Inhibition When Slightly Positively Charged. Pharmaceutics, MDPI, 2021, 13 (4), ⟨10.3390/pharmaceutics13040479⟩. ⟨hal-03290555⟩

Share

Metrics

Record views

5